Birgitte Andersen
14Patents
4h-index
26Co-inventors
56Inventor score
Filing activity: Jul 17, 2009 → Apr 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8232248B2 | Treatment of rheumatoid arthritis with mammal beta defensins | Human Necessities | 5 | Active |
| US8232242B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 5 | Active |
| US8802621B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 4 | Active |
| US9279010B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 4 | Active |
| US9895417B2 | FGF21 derivatives and uses thereof | Human Necessities | 2 | Active |
| US9744213B2 | FGF21 derivatives and uses thereof | Human Necessities | 2 | Active |
| US10124039B2 | FGF21 derivatives and uses thereof | Human Necessities | 2 | Active |
| US9480753B2 | FGF21 derivatives with albumin binder A-B-C-D-E- and their use | Human Necessities | 1 | Active |
| US9217021B2 | Oral treatment of inflammatory bowel disease | Chemistry; Metallurgy | 1 | Active |
| US10221404B2 | Method for modifying characteristics of a lipase | Chemistry; Metallurgy | 1 | Active |
| US11578329B2 | Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression | Chemistry; Metallurgy | 0 | Active |
| US12378542B2 | Solid stabilized laccase compositions | Chemistry; Metallurgy | 0 | Active |
| US10851356B2 | Method for modifying characteristics of a lipase | Chemistry; Metallurgy | 0 | Active |
| US9833495B2 | Oral treatment of inflammatory bowel disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.